Blauvelt, A. ., Iversen, L., McBride, S. ., Gooderham, M., Staubach, P., Yamauchi, P., Staelens, F., Vanoorden, V., White, K. ., & Gisondi, P. (2021). Bimekizumab versus secukinumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial. SKIN The Journal of Cutaneous Medicine, 5(6), s53.